• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成年哺乳动物心脏中的固有免疫:细胞为谁敲响警钟。

Innate immunity in the adult mammalian heart: for whom the cell tolls.

作者信息

Mann Douglas L, Topkara Veli K, Evans Sarah, Barger Philip M

机构信息

Division of Cardiology, 660 S. Euclid Ave, Campus Box 8086, St. Louis, MO 63110, USA.

出版信息

Trans Am Clin Climatol Assoc. 2010;121:34-50; discussion 50-1.

PMID:20697548
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2917144/
Abstract

Recent studies suggest that the heart possesses an intrinsic system that is intended to delimit tissue injury, as well as orchestrate homoeostatic responses within the heart. The extant literature suggests that this intrinsic stress response is mediated, at least in part, by a family of pattern recognition receptors that belong to the innate immune system, including CD14, the soluble pattern recognition receptor for lipopolysaccharide, and Toll like receptors-2, 3, 4, and 6. Although this intrinsic stress response system provides a short-term adaptive response to tissue injury, the beneficial effects of this phylogenetically ancient system may be lost if myocardial expression of these molecules either becomes sustained and/or excessive, in which case the salutary effects of activation of these pathways may be contravened by the known deleterious effects of inflammatory signaling. Herein we present new information with regard to activation of innate immune gene expression in the failing human heart. Taken together, these new observations provide provisional evidence that the innate immune system is activated in human heart failure, raising the interesting possibility that this pathway may represent a target for the development of novel heart failure therapeutics.

摘要

最近的研究表明,心脏拥有一个内在系统,旨在限制组织损伤,并协调心脏内的稳态反应。现有文献表明,这种内在应激反应至少部分是由属于先天免疫系统的一类模式识别受体介导的,包括CD14(脂多糖的可溶性模式识别受体)以及Toll样受体-2、3、4和6。尽管这种内在应激反应系统为组织损伤提供了短期适应性反应,但如果这些分子在心肌中的表达持续存在和/或过度,这个进化上古老的系统的有益作用可能会丧失,在这种情况下,这些途径激活的有益效果可能会被炎症信号已知的有害作用所抵消。在此,我们展示了关于衰竭人类心脏中先天免疫基因表达激活的新信息。综上所述,这些新观察结果提供了初步证据,表明先天免疫系统在人类心力衰竭中被激活,这增加了一个有趣的可能性,即该途径可能代表新型心力衰竭治疗方法开发的一个靶点。

相似文献

1
Innate immunity in the adult mammalian heart: for whom the cell tolls.成年哺乳动物心脏中的固有免疫:细胞为谁敲响警钟。
Trans Am Clin Climatol Assoc. 2010;121:34-50; discussion 50-1.
2
Therapeutic targeting of innate immunity in the failing heart.衰竭心脏中固有免疫的治疗靶向。
J Mol Cell Cardiol. 2011 Oct;51(4):594-9. doi: 10.1016/j.yjmcc.2010.11.003. Epub 2010 Nov 10.
3
The emerging role of innate immunity in the heart and vascular system: for whom the cell tolls.先天免疫在心脏和血管系统中的新作用:细胞为谁敲响警钟。
Circ Res. 2011 Apr 29;108(9):1133-45. doi: 10.1161/CIRCRESAHA.110.226936.
4
Role of toll-like receptors in myocardial infarction.Toll样受体在心肌梗死中的作用。
J Recept Signal Transduct Res. 2015;35(5):420-2. doi: 10.3109/10799893.2014.993649. Epub 2014 Dec 17.
5
The innate immune response in reperfused myocardium.再灌注心肌中的固有免疫反应。
Cardiovasc Res. 2012 May 1;94(2):276-83. doi: 10.1093/cvr/cvs018. Epub 2012 Jan 20.
6
RAGE and TLRs: relatives, friends or neighbours?RAGE 和 TLRs:亲戚、朋友还是邻居?
Mol Immunol. 2013 Dec;56(4):739-44. doi: 10.1016/j.molimm.2013.07.008. Epub 2013 Aug 14.
7
Regulation of Toll-like receptor signaling pathways in innate immune responses.先天免疫反应中 Toll 样受体信号通路的调控。
Ann N Y Acad Sci. 2013 Apr;1283:67-74. doi: 10.1111/j.1749-6632.2012.06786.x. Epub 2012 Nov 19.
8
Innate immunity as a target for acute cardioprotection.先天免疫作为急性心脏保护的靶点。
Cardiovasc Res. 2019 Jun 1;115(7):1131-1142. doi: 10.1093/cvr/cvy304.
9
Innate immunity and inflammation--New frontiers in comparative cardiovascular pathology.固有免疫与炎症——比较心血管病理学的新前沿
Cardiovasc Res. 2007 Jan 1;73(1):26-36. doi: 10.1016/j.cardiores.2006.08.009. Epub 2006 Aug 22.
10
Innate immunity and remodelling.先天免疫与重塑。
Heart Fail Rev. 2011 Jan;16(1):71-8. doi: 10.1007/s10741-010-9187-1.

引用本文的文献

1
Immune patterns of cuproptosis in ischemic heart failure: A transcriptome analysis.缺血性心力衰竭中铜死亡的免疫模式:转录组分析。
J Cell Mol Med. 2024 Apr;28(7):e18187. doi: 10.1111/jcmm.18187.
2
Emerging Roles for Dendritic Cells in Heart Failure.树突状细胞在心力衰竭中的新作用。
Biomolecules. 2023 Oct 17;13(10):1535. doi: 10.3390/biom13101535.
3
Effects of Inflammatory Cell Death Caused by Catheter Ablation on Atrial Fibrillation.导管消融引起的炎性细胞死亡对心房颤动的影响。
J Inflamm Res. 2023 Aug 17;16:3491-3508. doi: 10.2147/JIR.S422002. eCollection 2023.
4
The Predictive Value of Eosinophil Indices for Major Cardiovascular Events in Patients with Acute Decompensated HFrEF.嗜酸性粒细胞指数对急性失代偿性射血分数降低心衰患者主要心血管事件的预测价值。
Medicina (Kaunas). 2022 Oct 15;58(10):1455. doi: 10.3390/medicina58101455.
5
Dysregulation and imbalance of innate and adaptive immunity are involved in the cardiomyopathy progression.先天性和适应性免疫的失调与失衡参与了心肌病的进展。
Front Cardiovasc Med. 2022 Sep 6;9:973279. doi: 10.3389/fcvm.2022.973279. eCollection 2022.
6
Heart Failure in Chronic Infectious and Inflammatory Conditions: Mechanistic Insights from Clinical Heterogeneity.慢性感染和炎症性疾病中的心力衰竭:临床异质性的机制见解。
Curr Heart Fail Rep. 2022 Oct;19(5):267-278. doi: 10.1007/s11897-022-00560-3. Epub 2022 Jul 15.
7
Mitochondrial DNA Is a Vital Driving Force in Ischemia-Reperfusion Injury in Cardiovascular Diseases.线粒体 DNA 是心血管疾病缺血再灌注损伤的重要驱动力。
Oxid Med Cell Longev. 2022 May 17;2022:6235747. doi: 10.1155/2022/6235747. eCollection 2022.
8
Innate Immune Pathways Promote Oligodendrocyte Progenitor Cell Recruitment to the Injury Site in Adult Zebrafish Brain.先天免疫途径促进成年斑马鱼大脑中少突胶质前体细胞向损伤部位募集。
Cells. 2022 Feb 2;11(3):520. doi: 10.3390/cells11030520.
9
Inflammatory Burden and Immunomodulative Therapeutics of Cardiovascular Diseases.心血管疾病的炎症负担与免疫调节疗法
Int J Mol Sci. 2022 Jan 12;23(2):804. doi: 10.3390/ijms23020804.
10
Biological Activities of Paeonol in Cardiovascular Diseases: A Review.丹皮酚在心血管疾病中的生物学活性:综述。
Molecules. 2021 Aug 17;26(16):4976. doi: 10.3390/molecules26164976.

本文引用的文献

1
Toll-like receptor signaling: a critical modulator of cell survival and ischemic injury in the heart.Toll样受体信号传导:心脏细胞存活和缺血性损伤的关键调节因子。
Am J Physiol Heart Circ Physiol. 2009 Jan;296(1):H1-12. doi: 10.1152/ajpheart.00995.2008. Epub 2008 Nov 14.
2
Innate immune adaptor MyD88 mediates neutrophil recruitment and myocardial injury after ischemia-reperfusion in mice.先天性免疫衔接蛋白MyD88介导小鼠缺血再灌注后的中性粒细胞募集和心肌损伤。
Am J Physiol Heart Circ Physiol. 2008 Sep;295(3):H1311-H1318. doi: 10.1152/ajpheart.00119.2008. Epub 2008 Jul 25.
3
Toll-like receptor-4 modulates survival by induction of left ventricular remodeling after myocardial infarction in mice.Toll样受体4通过诱导小鼠心肌梗死后左心室重构来调节生存。
J Immunol. 2008 May 15;180(10):6954-61. doi: 10.4049/jimmunol.180.10.6954.
4
What is principal component analysis?什么是主成分分析?
Nat Biotechnol. 2008 Mar;26(3):303-4. doi: 10.1038/nbt0308-303.
5
Toll-like receptor 4 deficiency: smaller infarcts, but no gain in function.Toll样受体4缺陷:梗死灶较小,但功能未改善。
BMC Physiol. 2007 Jun 25;7:5. doi: 10.1186/1472-6793-7-5.
6
Toll-like receptors 2-deficient mice are protected against postischemic coronary endothelial dysfunction.Toll样受体2缺陷型小鼠可免受缺血后冠状动脉内皮功能障碍的影响。
Arterioscler Thromb Vasc Biol. 2007 May;27(5):1064-71. doi: 10.1161/ATVBAHA.107.140723. Epub 2007 Mar 1.
7
Inhibition of Toll-like receptor 4 with eritoran attenuates myocardial ischemia-reperfusion injury.依替膦酸抑制Toll样受体4可减轻心肌缺血再灌注损伤。
Circulation. 2006 Jul 4;114(1 Suppl):I270-4. doi: 10.1161/CIRCULATIONAHA.105.000901.
8
MyD88 and NOS2 are essential for toll-like receptor 4-mediated survival effect in cardiomyocytes.髓样分化因子88(MyD88)和一氧化氮合酶2(NOS2)对于Toll样受体4介导的心肌细胞存活效应至关重要。
Am J Physiol Heart Circ Physiol. 2006 Oct;291(4):H1900-9. doi: 10.1152/ajpheart.00112.2006. Epub 2006 Apr 28.
9
Immune cell Toll-like receptor 4 is required for cardiac myocyte impairment during endotoxemia.在内毒素血症期间,免疫细胞Toll样受体4是心肌细胞损伤所必需的。
Circ Res. 2004 Oct 1;95(7):700-7. doi: 10.1161/01.RES.0000144175.70140.8c. Epub 2004 Sep 9.
10
Toll-like receptor 4 mediates ischemia/reperfusion injury of the heart.Toll样受体4介导心脏缺血/再灌注损伤。
J Thorac Cardiovasc Surg. 2004 Aug;128(2):170-9. doi: 10.1016/j.jtcvs.2003.11.036.